wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q38221107-A29DB86C-B0CF-45BC-A266-8BE9A0AAC158
Q38221107-A29DB86C-B0CF-45BC-A266-8BE9A0AAC158
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38221107-A29DB86C-B0CF-45BC-A266-8BE9A0AAC158
Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.
P2860
Q38221107-A29DB86C-B0CF-45BC-A266-8BE9A0AAC158
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38221107-A29DB86C-B0CF-45BC-A266-8BE9A0AAC158
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d9cfde9d2b44b2ff0eea9c8d0f6c8410b56a48fe
P2860
Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells.